{
  "docId": "019de518-6502-70bc-9a44-c6a9c7f323b5",
  "docSlug": "4230ce80abe7092521a593effe59cbcd",
  "documentTitle": "Oculis | Investor Presentation Deck | 48 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 48,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 6,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de518-6502-70bc-9a44-c6a9c7f323b5/19",
  "deckHref": "/decks/019de518-6502-70bc-9a44-c6a9c7f323b5",
  "deckJsonHref": "/decks/019de518-6502-70bc-9a44-c6a9c7f323b5.json",
  "deckAnchorHref": "/decks/019de518-6502-70bc-9a44-c6a9c7f323b5#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.049,
        "w": 0.118,
        "x": 0.85,
        "y": 0.04
      },
      "kind": "image",
      "text": "Oculis",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c643dd57-5bed-40d3-8e17-7a1f10745cd5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.046,
        "w": 0.708,
        "x": 0.257,
        "y": 0.159
      },
      "kind": "list",
      "text": "Results validated induction and maintenance regimen to optimize OCS-01 efficacy potential in DME with robust statistical significance",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0cc0c41f-d5d5-4352-9bef-c89c03a49051",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.44,
        "x": 0.257,
        "y": 0.62
      },
      "kind": "list",
      "text": "No unexpected safety findings observed",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "90cb99d7-c17d-4936-a99c-304aae8d48f1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.708,
        "x": 0.257,
        "y": 0.389
      },
      "kind": "list",
      "text": "Increase in proportion of patients with a 3-line or greater gain (Clinical Benefit Endpoint) 25.3% with OCS-01 vs. 9.8% (p = 0.015)",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a099db3c-3230-42e4-9320-4f652e132295",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.699,
        "x": 0.257,
        "y": 0.358
      },
      "kind": "list",
      "text": "Improvement of visual acuity (Functional Endpoint) +7.2 with OCS-01 vs. +3.1 (p = 0.007)",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b255505d-81f9-43e5-bc36-4296e87239e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.046,
        "w": 0.708,
        "x": 0.257,
        "y": 0.303
      },
      "kind": "list",
      "text": "OCS-01 met all functional and clinical benefit endpoints in a robust, statistically superior manner (in 3-month trial):",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b3361372-1af0-4001-8046-cecb191146bc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.708,
        "x": 0.257,
        "y": 0.45
      },
      "kind": "list",
      "text": "Reduction in macular edema as measured by OCT imaging (Pharmacodynamic Endpoint) - 63.6 µm with OCS-01 vs. +5.5 µm (p < 0.0001)",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c80a9ef3-6a68-40bb-b61f-b1bfc98967c4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.046,
        "w": 0.159,
        "x": 0.045,
        "y": 0.39
      },
      "kind": "other",
      "text": "Functional & Clinical Benefits",
      "attrs": {},
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "35ef2fa1-1427-4cbc-8c8d-d29cea811b40",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.046,
        "w": 0.159,
        "x": 0.045,
        "y": 0.173
      },
      "kind": "other",
      "text": "Trial Objectives Met",
      "attrs": {},
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77e98956-565c-41e0-85c5-bc952c08b7f3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.018,
        "w": 0.018,
        "x": 0.94,
        "y": 0.95
      },
      "kind": "other",
      "text": "19",
      "attrs": {},
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e70869b-9890-4203-8f1c-919fe6dcd682",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.159,
        "x": 0.045,
        "y": 0.62
      },
      "kind": "other",
      "text": "Safety",
      "attrs": {},
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e7669c53-30f5-4d3d-9596-f5191fa7bd9e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.75,
        "x": 0.125,
        "y": 0.795
      },
      "kind": "paragraph",
      "text": "Next Step: Complete Stage 2 of Phase 3 program to support NDA filing of OCS-01 for DME treatment",
      "attrs": {},
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63739099-8754-4d21-b51e-989c00527af8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.809,
        "x": 0.026,
        "y": 0.049
      },
      "kind": "title",
      "text": "Positive OCS-01 Phase 3 Stage 1 Results De-risking Stage 2 Trial",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "72ecdb9a-1ca0-4580-b4e5-a3e34fe09e98",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "4e288066-f111-46fd-a2c1-65e0a77c73e5",
      "evidence": "list/bullet: Results validated induction and maintenance regimen to optimize OCS-01 efficacy potential in DME with robust statistical significance",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}